A detailed history of Nisa Investment Advisors, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 1,696 shares of SUPN stock, worth $57,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,696
Previous 1,650 2.79%
Holding current value
$57,918
Previous $44,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$25.77 - $35.16 $1,185 - $1,617
46 Added 2.79%
1,696 $52,000
Q2 2024

Jul 19, 2024

SELL
$25.99 - $33.85 $10,084 - $13,133
-388 Reduced 19.04%
1,650 $44,000
Q1 2024

May 01, 2024

BUY
$27.11 - $35.17 $13,094 - $16,987
483 Added 31.06%
2,038 $69,000
Q4 2023

Jan 25, 2024

SELL
$22.72 - $29.68 $27,036 - $35,319
-1,190 Reduced 43.35%
1,555 $45,000
Q3 2023

Nov 02, 2023

SELL
$27.57 - $32.91 $275 - $329
-10 Reduced 0.36%
2,745 $75,000
Q2 2023

Aug 11, 2023

SELL
$29.91 - $38.73 $17,347 - $22,463
-580 Reduced 17.39%
2,755 $82,000
Q1 2023

May 02, 2023

SELL
$34.93 - $42.03 $3,143 - $3,782
-90 Reduced 2.63%
3,335 $121,000
Q3 2022

Nov 07, 2022

BUY
$28.79 - $35.41 $1,007 - $1,239
35 Added 1.03%
3,425 $117,000
Q2 2022

Aug 03, 2022

BUY
$25.33 - $34.25 $18,997 - $25,687
750 Added 28.41%
3,390 $98,000
Q1 2022

Apr 29, 2022

SELL
$28.51 - $32.9 $114,125 - $131,698
-4,003 Reduced 60.26%
2,640 $85,000
Q4 2021

Feb 03, 2022

BUY
$26.37 - $34.22 $73,915 - $95,918
2,803 Added 72.99%
6,643 $205,000
Q3 2021

Oct 18, 2021

BUY
$23.54 - $31.39 $2,354 - $3,139
100 Added 2.67%
3,840 $102,000
Q2 2021

Aug 06, 2021

BUY
$26.72 - $33.19 $7,748 - $9,625
290 Added 8.41%
3,740 $115,000
Q4 2020

Jan 25, 2021

BUY
$17.7 - $25.81 $3,894 - $5,678
220 Added 6.81%
3,450 $87,000
Q3 2020

Oct 20, 2020

SELL
$20.2 - $25.05 $450,399 - $558,539
-22,297 Reduced 87.35%
3,230 $67,000
Q2 2020

Jul 27, 2020

BUY
$17.09 - $24.89 $399,222 - $581,430
23,360 Added 1077.99%
25,527 $606,000
Q1 2020

Apr 17, 2020

BUY
$14.45 - $24.69 $8,670 - $14,814
600 Added 38.29%
2,167 $39,000
Q4 2019

Jan 17, 2020

SELL
$19.93 - $29.13 $163,485 - $238,953
-8,203 Reduced 83.96%
1,567 $37,000
Q3 2019

Oct 17, 2019

BUY
$25.47 - $33.37 $15,103 - $19,788
593 Added 6.46%
9,770 $268,000
Q1 2019

Apr 17, 2019

BUY
$32.77 - $41.99 $290,243 - $371,905
8,857 Added 2767.81%
9,177 $322,000
Q1 2018

Apr 10, 2018

SELL
$37.15 - $46.9 $1,857 - $2,345
-50 Reduced 13.51%
320 $15,000
Q3 2017

Oct 13, 2017

BUY
$36.75 - $49.65 $13,597 - $18,370
370
370 $15,000

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.83B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.